Drug Price Trends for NDC 00093-5030

Average Pharmacy Cost for 00093-5030

Drug Name	NDC	Price/Unit ($)	Unit	Date
TIAGABINE HCL 2 MG TABLET	00093-5030-56	2.03746	EACH	2025-04-23
TIAGABINE HCL 2 MG TABLET	00093-5030-56	2.17280	EACH	2025-03-19
TIAGABINE HCL 2 MG TABLET	00093-5030-56	2.19295	EACH	2025-02-19

Best Wholesale Price for NDC 00093-5030

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Drug Name	Vendor	NDC	Count	Price ($)	Price/Unit ($)	Dates	Price Type
No data available in table

Market Analysis and Price Projections for NDC 00093-5030: Navigating the Pharmaceutical Landscape

The pharmaceutical industry is a complex and ever-evolving sector, with drug pricing and market trends playing crucial roles in shaping its future. In this comprehensive analysis, we'll delve into the market dynamics and price projections for the drug identified by the National Drug Code (NDC) 00093-5030. While the specific drug associated with this NDC is not provided in the search results, we can explore general trends and factors that influence drug pricing and market positioning in the pharmaceutical industry.

Understanding the National Drug Code (NDC)

Before we dive into the market analysis, it's essential to understand what an NDC represents. The National Drug Code is a unique, three-segment number assigned by the U.S. Food and Drug Administration (FDA) to human drugs in the United States[9]. It serves as a universal product identifier for drugs and plays a crucial role in various aspects of the pharmaceutical supply chain, including pricing, reimbursement, and regulatory compliance.

The Structure of NDC 00093-5030

The NDC 00093-5030 can be broken down as follows:

• Labeler Code: 00093
• Product Code: 503
• Package Code: 0

The labeler code "00093" is associated with Teva Pharmaceuticals USA, Inc., a major player in the generic drug market[8]. However, without more specific information about the drug itself, we'll need to analyze broader market trends that could impact its pricing and market position.

Current Pharmaceutical Market Trends

To understand the potential market dynamics for the drug associated with NDC 00093-5030, let's examine some of the key trends shaping the pharmaceutical industry in 2024 and beyond.

Revenue Growth and Price Erosion

The pharmaceutical industry is experiencing a mix of revenue growth and price erosion, particularly in the generic drug sector. In 2024, we're seeing:

• Mid-single-digit percent annual price erosion in generic drugs
• A return to modest revenue growth, improving from recent trends[3]

This balance between growth and erosion suggests a competitive market where manufacturers must carefully navigate pricing strategies to maintain profitability while remaining competitive.

Rise of Biosimilars and Immunotherapies

Two key areas driving significant changes in the pharmaceutical landscape are biosimilars and immunotherapies:

• Biosimilars are projected to see substantial revenue growth, although intense competition may limit profitability.
• Immunotherapies, especially in markets like non-small cell lung cancer (NSCLC), are expected to drive significant sales[4].

For instance, drugs like Keytruda, Opdivo, and Tecentriq are projected to achieve blockbuster status by 2025, with combined sales of $17.5 billion in the NSCLC market alone[4].

Factors Influencing Drug Pricing

Several factors play a role in determining drug prices and market positioning. Understanding these can help predict potential pricing strategies for NDC 00093-5030.

Patent Status and Market Exclusivity

The patent status of a drug significantly impacts its pricing:

• Patented drugs often command higher prices due to market exclusivity.
• Generic versions typically enter the market at lower prices once patents expire.

For example, the sales of Tarceva, a patented drug, are expected to drop from $783 million in 2015 to $18 million by 2025 as generic versions become available[4].

Competition and Market Dynamics

The level of competition in a drug's therapeutic class can greatly influence its pricing:

• Drugs with limited competition may maintain higher prices.
• Increased competition, especially from generics or biosimilars, often leads to price erosion.

"A lack of therapeutically equivalent drugs—both generics and other brand-name drugs used to treat the same condition—and limited competition may contribute to extraordinary price increases."[3]

Regulatory Environment

The regulatory landscape plays a crucial role in drug pricing:

• FDA inspections of manufacturing facilities can impact pricing strategies.
• Price-fixing litigation can affect the generic drug industry's pricing approaches[3].

Economic Factors

Broader economic considerations also influence drug pricing:

• Healthcare spending trends
• Reimbursement policies
• Overall economic conditions

For instance, the high cost of combination therapies may limit their uptake despite therapeutic benefits[4].

Price Projections for NDC 00093-5030

While we don't have specific information about the drug associated with NDC 00093-5030, we can make some general projections based on industry trends:

Generic Drug Scenario

If NDC 00093-5030 represents a generic drug:

• It may face mid-single-digit percent annual price erosion.
• The manufacturer might focus on volume sales to maintain profitability.
• Price competition could be intense, especially if multiple generics are available for the same molecule.

Branded Drug Scenario

If NDC 00093-5030 is a branded drug:

• It may maintain higher prices, especially if it offers unique therapeutic benefits.
• The pricing strategy could depend on its patent status and the presence of competing therapies.
• If it's a specialty drug, it might command premium pricing based on its efficacy and target patient population.

Biosimilar Scenario

In the case of a biosimilar:

• Initial pricing might be set at a 15-30% discount compared to the reference biologic.
• Price erosion could occur over time as more biosimilars enter the market.
• The pricing strategy may focus on gaining market share while balancing profitability.

Market Positioning Strategies

To navigate the complex pharmaceutical landscape, manufacturers of NDC 00093-5030 might consider the following strategies:

Differentiation

• Highlighting unique features or benefits of the drug
• Focusing on specific patient populations or indications
• Emphasizing quality and reliability, especially for generic manufacturers

Value-Based Pricing

• Aligning pricing with demonstrated clinical outcomes
• Engaging in risk-sharing agreements with payers
• Offering patient assistance programs to improve access

Supply Chain Optimization

• Improving manufacturing efficiency to reduce costs
• Ensuring a stable supply to build trust with healthcare providers and patients
• Exploring vertical integration opportunities

Future Outlook for the Pharmaceutical Industry

Looking ahead, several trends are likely to shape the future of the pharmaceutical market:

Personalized Medicine

The rise of personalized medicine and targeted therapies could lead to:

• More niche drugs with potentially higher prices
• Increased focus on biomarkers and genetic testing
• Challenges in pricing and reimbursement models for highly specialized treatments

Digital Health Integration

The integration of digital health technologies may impact drug pricing and market positioning:

• Opportunities for value-based contracts leveraging real-world data
• Enhanced patient monitoring and adherence programs
• Potential for combination products (drug + digital therapeutic)

Sustainability and Environmental Considerations

Growing emphasis on sustainability could influence manufacturing and pricing:

• Investments in green manufacturing processes
• Potential premium pricing for environmentally friendly drug production
• Increased scrutiny of supply chain sustainability

Key Takeaways

• The pharmaceutical market is experiencing a mix of revenue growth and price erosion, with generic drugs facing mid-single-digit annual price decreases.
• Biosimilars and immunotherapies are driving significant market changes and sales growth.
• Drug pricing is influenced by factors such as patent status, competition, regulatory environment, and economic conditions.
• Without specific information on NDC 00093-5030, projections must be based on general industry trends for generic, branded, or biosimilar drugs.
• Future market positioning strategies may focus on differentiation, value-based pricing, and supply chain optimization.
• The pharmaceutical industry is evolving towards personalized medicine, digital health integration, and increased focus on sustainability.

FAQs

1. Q: How often are drug prices typically adjusted in the pharmaceutical industry? A: Drug prices can be adjusted annually or more frequently, depending on market conditions, competition, and regulatory factors. In 2024, for example, prices for many medications went up by an average of about 4.5% at the beginning of the year[10].

2. Q: What role does the FDA play in drug pricing? A: While the FDA doesn't directly control drug prices, its regulatory actions, such as approving new drugs or generics, can significantly impact market competition and, consequently, pricing dynamics.

3. Q: How might the rise of personalized medicine affect drug pricing? A: Personalized medicine may lead to higher prices for targeted therapies due to smaller patient populations and potentially higher development costs. However, it may also result in better outcomes and potentially lower overall healthcare costs.

4. Q: What are some strategies pharmaceutical companies use to maintain profitability in the face of price erosion? A: Companies may focus on increasing volume sales, optimizing manufacturing processes, diversifying their product portfolio, or expanding into new markets to maintain profitability.

5. Q: How do international markets influence drug pricing in the United States? A: International markets can influence U.S. drug pricing through reference pricing policies, parallel importation discussions, and global competition for pharmaceutical investment and innovation.

Sources cited: [3] https://www.gao.gov/assets/gao-10-201.pdf [4] https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory [8] https://www.drugpatentwatch.com/p/drug-price/ndc/00093-8739 [9] https://www.fda.gov/drugs/development-approval-process-drugs/national-drug-code-database-background-information [10] https://www.maxor.com/pbm-2024-year-in-review/